SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-260467
Filing Date
2017-08-17
Accepted
2017-08-17 09:07:35
Documents
7
Period of Report
2017-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d441595d8k.htm 8-K 38841
2 EX-1.1 d441595dex11.htm EX-1.1 235522
3 EX-2.1 d441595dex21.htm EX-2.1 328219
4 EX-3.1 d441595dex31.htm EX-3.1 254098
5 EX-4.1 d441595dex41.htm EX-4.1 120803
6 EX-99.1 d441595dex991.htm EX-99.1 10171
7 GRAPHIC g441595g0817110220554.jpg GRAPHIC 2956
  Complete submission text file 0001193125-17-260467.txt   993199
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 171037737
SIC: 2834 Pharmaceutical Preparations